FDA Inspection
NAMSANAMSA – FDA Inspection, Sep 15, 2017
Record Details
This FDA Inspection record concerns NAMSA, with an inspection on September 15, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · f0cc42ba-d14f-4f42-ad25-9ccbd45b9421
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1026806
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
- Outcome
- Form 483 issued
Other FDA inspections of NAMSA
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 27, 2019 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| June 11, 2014 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| April 5, 2012 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| March 31, 2010 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
Other documents for NAMSA
- FDA Inspection 1084597 - 2019-03-27
- FDA Inspection 904618 - 2014-06-11
- FDA Inspection 788447 - 2012-04-05
- FDA Inspection 683802 - 2010-03-31
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.